These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine]. Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790 [TBL] [Abstract][Full Text] [Related]
7. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study. Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378 [TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373 [TBL] [Abstract][Full Text] [Related]
9. Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. Lambert M; Conus P; Cotton S; Robinson J; McGorry PD; Schimmelmann BG J Clin Psychopharmacol; 2010 Oct; 30(5):565-72. PubMed ID: 20814327 [TBL] [Abstract][Full Text] [Related]
10. Pretreatment predictors of cognitive deficits in early psychosis. González-Blanch C; Crespo-Facorro B; Alvarez-Jiménez M; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Barquero JL Psychol Med; 2008 May; 38(5):737-46. PubMed ID: 17922942 [TBL] [Abstract][Full Text] [Related]
11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
12. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions. Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915 [TBL] [Abstract][Full Text] [Related]
13. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Aparasu RR; Jano E; Johnson ML; Chen H Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375 [TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of first episode psychosis in Estonia: comparison with national and international treatment guidelines. Lass J; Männik A; Bell JS J Clin Pharm Ther; 2008 Apr; 33(2):165-73. PubMed ID: 18315782 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the initial treatment phase in first-episode psychosis. Power P; Elkins K; Adlard S; Curry C; McGorry P; Harrigan S Br J Psychiatry Suppl; 1998; 172(33):71-6. PubMed ID: 9764130 [TBL] [Abstract][Full Text] [Related]
16. Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFIP study. Crespo-Facorro B; de la Foz VO; Ayesa-Arriola R; Pérez-Iglesias R; Mata I; Suarez-Pinilla P; Tabares-Seisdedos R; Vázquez-Barquero JL Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():162-7. PubMed ID: 23435091 [TBL] [Abstract][Full Text] [Related]
17. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. Honer WG; Kopala LC; Rabinowitz J J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513 [TBL] [Abstract][Full Text] [Related]
18. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit. Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409 [TBL] [Abstract][Full Text] [Related]
19. [Prognosis of short-term outcome in the first admission for psychosis]. Verdoux H; Liraud F; Gonzales B; Fournet O; Pauillac P; Assens F; Abalan F; Beaussier JP; Gaussares C; Etchegaray B; Bourgeois M Encephale; 1999; 25(3):213-20. PubMed ID: 10434146 [TBL] [Abstract][Full Text] [Related]
20. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years. Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]